146 related articles for article (PubMed ID: 30699922)
1. A Call for Systems Epidemiology to Tackle the Complexity of Schistosomiasis, Its Control, and Its Elimination.
Krauth SJ; Balen J; Gobert GN; Lamberton PHL
Trop Med Infect Dis; 2019 Jan; 4(1):. PubMed ID: 30699922
[TBL] [Abstract][Full Text] [Related]
2. Gene drives for schistosomiasis transmission control.
Maier T; Wheeler NJ; Namigai EKO; Tycko J; Grewelle RE; Woldeamanuel Y; Klohe K; Perez-Saez J; Sokolow SH; De Leo GA; Yoshino TP; Zamanian M; Reinhard-Rupp J
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007833. PubMed ID: 31856157
[TBL] [Abstract][Full Text] [Related]
3. Socio-ecological dynamics and challenges to the governance of Neglected Tropical Disease control.
Michael E; Madon S
Infect Dis Poverty; 2017 Feb; 6(1):35. PubMed ID: 28166826
[TBL] [Abstract][Full Text] [Related]
4. Why reinvent the wheel? Lessons in schistosomiasis control from the past.
Shiff C
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005812. PubMed ID: 29073138
[TBL] [Abstract][Full Text] [Related]
5. Time to set the agenda for schistosomiasis elimination.
Rollinson D; Knopp S; Levitz S; Stothard JR; Tchuem Tchuenté LA; Garba A; Mohammed KA; Schur N; Person B; Colley DG; Utzinger J
Acta Trop; 2013 Nov; 128(2):423-40. PubMed ID: 22580511
[TBL] [Abstract][Full Text] [Related]
6. A multi-component integrated approach for the elimination of schistosomiasis in the People's Republic of China: design and baseline results of a 4-year cluster-randomised intervention trial.
Gray DJ; Li YS; Williams GM; Zhao ZY; Harn DA; Li SM; Ren MY; Feng Z; Guo FY; Guo JG; Zhou J; Dong YL; Li Y; Ross AG; McManus DP
Int J Parasitol; 2014 Aug; 44(9):659-68. PubMed ID: 24929133
[TBL] [Abstract][Full Text] [Related]
7. Schistosomiasis vaccine development: update on human clinical trials.
Molehin AJ
J Biomed Sci; 2020 Jan; 27(1):28. PubMed ID: 31969170
[TBL] [Abstract][Full Text] [Related]
8. Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.
Shuford KV; Turner HC; Anderson RM
Parasit Vectors; 2016 Jan; 9():29. PubMed ID: 26813098
[TBL] [Abstract][Full Text] [Related]
9. Modelling the effects of mass drug administration on the molecular epidemiology of schistosomes.
Lamberton PH; Crellen T; Cotton JA; Webster JP
Adv Parasitol; 2015 Mar; 87():293-327. PubMed ID: 25765198
[TBL] [Abstract][Full Text] [Related]
10. [Strengthening the control of goat schistosomiasis to facilitate the progress towards elimination of schistosomiasis in China].
Jiao-Jiao L
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2016 Oct; 28(5):481-484. PubMed ID: 29469476
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the National Schistosomiasis Control Programmes in The People's Republic of China.
Xu J; Steinman P; Maybe D; Zhou XN; Lv S; Li SZ; Peeling R
Adv Parasitol; 2016; 92():1-38. PubMed ID: 27137441
[TBL] [Abstract][Full Text] [Related]
12. Experiences and perspectives of community health workers from implementing treatment for schistosomiasis using the community directed intervention strategy in an informal settlement in Kisumu City, western Kenya.
Odhiambo GO; Musuva RM; Odiere MR; Mwinzi PN
BMC Public Health; 2016 Sep; 16():986. PubMed ID: 27634152
[TBL] [Abstract][Full Text] [Related]
13. [Progress and challenges of schistosomiasis elimination in China].
Jing X; Shan L; Chun-Li C; Shi-Zhu L; Xiao-Nong Z
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2018 Oct; 30(6):605-609. PubMed ID: 30891968
[TBL] [Abstract][Full Text] [Related]
14. Improving Access to Diagnostics for Schistosomiasis Case Management in Oyo State, Nigeria: Barriers and Opportunities.
Van GY; Onasanya A; van Engelen J; Oladepo O; Diehl JC
Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32443849
[TBL] [Abstract][Full Text] [Related]
15. Insights from quantitative and mathematical modelling on the proposed WHO 2030 goal for schistosomiasis.
NTD Modelling Consortium Schistosomiasis Group
Gates Open Res; 2019; 3():1517. PubMed ID: 31701091
[TBL] [Abstract][Full Text] [Related]
16. One hundred years of neglect in paediatric schistosomiasis.
Bustinduy AL; Wright S; Joekes EC; Kabatereine NB; Reinhard-Rupp J; King CH; Stothard JR
Parasitology; 2017 Oct; 144(12):1613-1623. PubMed ID: 28245890
[TBL] [Abstract][Full Text] [Related]
17. Elimination of schistosomiasis requires multifactorial diagnostics: evidence from high- and low-prevalence areas in the Nile Delta, Egypt.
Elmorshedy H; Bergquist R; Fayed A; Guirguis W; Abdel-Gawwad E; Eissa S; Barakat R
Infect Dis Poverty; 2020 Apr; 9(1):31. PubMed ID: 32241298
[TBL] [Abstract][Full Text] [Related]
18. Mass drug administration and the global control of schistosomiasis: successes, limitations and clinical outcomes.
Olveda DU; McManus DP; Ross AG
Curr Opin Infect Dis; 2016 Dec; 29(6):595-608. PubMed ID: 27584590
[TBL] [Abstract][Full Text] [Related]
19. The Geshiyaro Project: a study protocol for developing a scalable model of interventions for moving towards the interruption of the transmission of soil-transmitted helminths and schistosome infections in the Wolaita zone of Ethiopia.
Mekete K; Ower A; Dunn J; Sime H; Tadesse G; Abate E; Nigussu N; Seife F; McNaughton E; Anderson RM; Phillips AE
Parasit Vectors; 2019 Oct; 12(1):503. PubMed ID: 31665080
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
